larazotide acetate
Showing 1 - 25 of 1,049
Long COVID, Long COVID-19, Post Acute COVID-19 Syndrome Trial in Boston (Larazotide Acetate, Placebo)
Not yet recruiting
- Long COVID
- +3 more
- Larazotide Acetate
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 24, 2023
Covid19, Multisystem Inflammatory Syndrome in Children Trial in Boston (Larazotide Acetate, Placebo)
Recruiting
- Covid19
- Multisystem Inflammatory Syndrome in Children
- Larazotide Acetate
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Oct 6, 2021
Celiac Disease Trial in Boston (pancrelipase)
Terminated
- Celiac Disease
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Apr 20, 2021
Intradialytic Hypotension Trial in Béthune, Caen (ACETATE based dialysate, CITRATE based dialysate)
Not yet recruiting
- Intradialytic Hypotension
- ACETATE based dialysate
- CITRATE based dialysate
-
Béthune, France
- +1 more
Jun 29, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)
Not yet recruiting
- Infertility
- Biosimilar cetrorelix acetate
- Reference cetrorelix acetate
-
Xi'an, None Selected, ChinaHe Cai
Sep 7, 2023
Central Precocious Puberty Trial in Gyeonggi-do (Leuprolide Acetate 11.25 MG/ML)
Recruiting
- Central Precocious Puberty
- Leuprolide Acetate 11.25 MG/ML
-
Gyeonggi-do, Korea, Republic ofAjou University medical center
Aug 29, 2023
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic
Not yet recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
- (no location specified)
Sep 13, 2022
Acetoacetate and Acetate Metabolism in Chronic Kidney
Not yet recruiting
- Kidney Failure, Chronic
- PET scan metabolic day
- (no location specified)
Jul 20, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,
Active, not recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Los Angeles, California
- +6 more
Jan 18, 2023
Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova
Not yet recruiting
- Abnormal Uterine Bleeding
- +3 more
- Tranexamic acid 250 mg oral tablet
- Progynova 1 mg oral tablet
-
Bangkok, Ratchathewi, Thailand
- +1 more
Sep 27, 2023
Prostate Cancer, Metabolic Syndrome, Obesity Trial (Apple Cider Vinegar, Placebo)
Not yet recruiting
- Prostate Cancer
- +6 more
- Apple Cider Vinegar
- Placebo
- (no location specified)
Mar 24, 2023
Contraception Trial in Hershey (Norethindrone Acetate 5 MG, Norethindrone 0.35 MG)
Recruiting
- Contraception
- Norethindrone Acetate 5 MG
- Norethindrone 0.35 MG
-
Hershey, PennsylvaniaHershey Medical Center
Jan 20, 2023
Cataracts Infantile Trial in Barcelone (Clobetasol Propionate, Prednisolone acetate ophthalmic suspension, 1%)
Recruiting
- Cataracts Infantile
- Clobetasol Propionate
- Prednisolone acetate ophthalmic suspension, 1%
-
Barcelone, SpainHospìtal Sant Joan de Deu
Feb 1, 2023
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Experimental: 4 mg/day of WY-8678 (guanabenz acetate),
Active, not recruiting
- Nonalcoholic Fatty Liver
- Nonalcoholic Steatohepatitis
- Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
- Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
-
Yokohama, Kanagawa, JapanYokohama City University
Sep 25, 2022
Abiraterone Acetate in Indian Metastatic, Castration Resistant
Withdrawn
- Prostate Cancer
- Abiraterone Acetate
-
Bangalore, India
- +2 more
Aug 15, 2022
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;
Recruiting
- Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
- dalpiciclib; fluvestrant; compound gossypol acetate tablets
-
Hangzhou, Zhejiang, ChinazhejiangCH
Nov 9, 2023
Stroke, Acute Trial in Karachi (Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a
Recruiting
- Stroke, Acute
- Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a ratio 1;1, 2;1 and 3;1
-
Karachi, PakistanAga Khan University
May 19, 2023
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023